Method development and validation for simulataneous estimation of albendazole and praziquantel in bulk and in a synthetic mixture

Journal of Taibah University for Science

Volumn 8, Issue 1, 2014, Pages 54-63

  Shah, Shreya R ^a   Dey, S ^b   Pradhan, Prasanna ^a   Jain, H K ^a   Upadhyay, Umesh M ^a  

^a Sigma Institute of Pharmacy   (India)

^b Dr B C Roy College of Pharmacy and Allied Health Sciences   (India)

Author keywords

Albendazole; HPLC; Praziquantel; Simvastatin; UV detection; Validation

Indexed keywords

EID: 84981740166     PISSN: None     EISSN: 16583655     Source Type: Journal    
DOI: 10.1016/j.jtusci.2013.08.004     Document Type: Article

References (36)

1. A.FlisserE.SartiM.LightowlersP.SchantzNeurocysticercosis: regional status, epidemiology, impact and control measures in the AmericasActa Trop.8720034351
2. O.M.TakayanaguiTherapy for neurocysticercosisExpert Rev. Neurother.42004129139
3. O.H.Del BruttoSeminars on neurologyNeurocysticercosis252005243251
4. F.PolomaresG.PalenciaJ.R.AmbrosioA.OrtizH.Jung-CookEvaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studiesJ. Antimicrob. Chemother.572006482488
5. D.M.GuoS.P.XieJ.P.JiaTherapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosisChin. J. Parasitol. Parasit. Dis.212003187188
6. M.I.YasawyM.A.A.L.KarawiA.R.E.MohamedCombination of praziquantel and albendazole in the treatment of hydatid diseaseTrop. Med. Parasitol.441993192194
7. F.CoboC.YarnozB.SesmaP.FraileM.AizcorbeR.TrujilloA.Diazde- LiañoM.A.CigaAlbendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatidosis caused by Echinococcus granulosusTrop. Med. Int. Health31998462466
8. A.E.MohamedM.I.YasawyM.A.Al KarawiCombined albendazole and praziquantel versus albendazole alone in the treatment of hydatid diseaseHepatogastroenterology45199816901694
9. H.M.AylesE.L.CorbettI.TaylorA.G.A.CowieJ.BlighK.WalmsleyA.D.M.BrycesonA combined medical and surgical approach to hydatid disease: 12 years’ experience at the Hospital for Tropical DiseasesAnn. R. Coll. Surg. England842002100105
10. C.VillaverdeA.I.AlvarezP.RedondoJ.VocesJ.L.Del EstalJ.G.PrietoSmall intestinal sulphoxidation of albendazoleXenobiotica251995433441
11. E.A.FormentiniO.N.MestorinoE.L.MariñoJ.O.ErrecaldePharmacokinetics of ricobendazole in calvesJ. Vet. Pharmacol. Ther.242001199202
12. O.M.TakayanaguiP.S.BonatoS.A.C.DreossiV.L.LanchoteEnantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosisBr. J. Clin. Pharmacol.542002125130
13. A.GoudahAspects of the pharmacokinetics of albendazole sulphoxide in sheepVet. Res. Commun.272003555566
14. V.L.LanchoteO.M.TakayanaguiF.H.MateusEnantioselective renal excretion of albendazole metabolites in patients with neurocysticercosisChirality162004520525
15. K.PengsaaK.Na-BangchangK.LimkittikulK.KabkaewK.LapphraC.SirivichayakulP.WisetsingC.Pojjaroen-AnantP.ChanthavanichA.SbchareonPharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalisAnn. Trop. Med. Parasitol.982004349357
16. C.LerchG.BlaschkeInvestigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography–mass spectrometryJ. Chromatogr. B7081998267275
17. H.MeierG.BlaschkerInvestigation of praziquantel metabolism in isolated rat hepatocytesJ. Pharmaceut. Biomed. Anal.262001409415
18. A.Godawska-MatysikE.PekalaK.Kiec-KononowiczThe research on biotransformation of praziquantelActa Polon. Pharmaceut.6120047578
19. U.StaudtG.SchmahlG.BlaschkeH.MehlhornLight and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite on Schistosoma mansoni in vitroParasitol. Res.781992392397
20. F.WesthoffG.BlaschkeHigh-performance liquid chromatographic determination of the stereoselective biotransformation of the chiral drug praziquantelJ. Chromatogr.5781992265271
21. M.E.C.ValoisO.M.TakayanaguiP.S.BonatoV.L.LanchoteD.CarvalhoDetermination of albendazole metabolites in plasma by HPLCJ. Anal. Toxicol.1819948690
22. S.R.PoloJ.TorradoF.BolasS.TorradoA selective and simple RP-HPLC assay to quantify albendazole metabolites in plasmaJ. Liq. Chromatogr. Relat. Technol.21199823272340
23. J.J.GarciaF.Bolas-FernandezJ.J.TorradoQuantitative determination of albendazole and its main metabolites in plasmaJ. Chromatogr. B7231999265271
24. A.MirfazaelianS.DadashzadehM.R.RouiniA high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serumPharm. Pharmacol. Commun.62000563566
25. D.KitzmanK.J.ChengL.FleckensteinHPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studiesJ. Pharmaceut. Biomed. Anal.302002801813
26. W.RidtitidM.WongnawaW.MahatthanatrakulJ.PunyoM.SunbhanichLC determination of praziquantel in human plasmaJ. Pharmaceut. Biomed. Anal.282002181186
27. A.MirfazaelianS.DadashzadehM.R.RouiniA high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serumJ. Pharmaceut. Biomed. Anal.30200212491254
28. R.SarinA.P.DashV.K.DuaAlbendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatographyJ. Chromatogr. B7992004233238
29. Z.WuN.J.MedlicottM.RazzakI.G.TuckerDevelopment and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasmaJ. Pharmaceut. Biomed. Anal.392005225232
30. A.ProcházkovaM.ChoukiR.TheurillatW.ThormannTherapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresisElectrophoresis212000729736
31. H.MeierG.BlaschkeInvestigation of praziquantel metabolism in isolated rat hepatocytesJ. Chromatogr. B7482000221231
32. P.S.BonatoV.L.LanchoteO.M.TakayanaguiSimultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasmaJ. Chromatogr. B7832003237245
33. X.ChenL.ZhaoH.XuD.ZhongSimultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric methodJ. Pharmaceut. Biomed. Anal.352004829836
34. A.J.B.MeloY.IamamotoA.P.J.MaestrinJ.R.L.SmithM.D.SantosN.P.LopesP.S.BonatoBiomimetic oxidation of praziquantel catalysed by metalloporphyrinsJ. Mol. Catal. A Chem.22620052331
35. ICH Guidelines: Validation of Analytical Procedures: Q2B, 1996.
36. ICH Guidelines: Validation of Analytical Procedures: Q2A, 1994.